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THE evidence for the radiosensitizing action of 2-methyl-1:4-naphthohydro-
quinone diphosphate (Synkavit) in biological systems has been reviewed in a
previous paper in this series, and in an investigation ofthe possible mode ofaction
ofthis compound, it was shown that Synkavit seemed to inhibit synthesis of RNA
from acid soluble precursors in cells ofthe Ehrlich mouse ascites tumour (Marrian,
1959.)
Hanel, Hjort and Purser (1958), also investigating possible mechanisms for
the radiosensitizing action, showed that injections of Synkavit into normal rats
shortly before X-irradiation increased the stimulation of endogenous respiration
of liver slices caused by radiation. Synkavit alone stimulated this system at
high doses and it was suggested that the radiosensitizing action was due to this
radiomimetic effect. In another study on the ascites tumour (Tiedemann, Risse
and Born, 1958) it was shown that both Synkavit and the corresponding quinone
inhibited glycolysis. At 5 x 10-5 molar, the quinone stimulated oxygen uptake,
but at higher concentrations there was either a smaller stimulation or a slight
inhibition. The most marked effect was the almost complete inhibition of aerobic
glycolysis at concentrations as low as 1 x 10-5 molar.
In view of the importance of quinones of the Vitamin K and Co-enzyme Q
type in electron transport (Russell and Brodie, 1961 ; Wattenberg, 1961) and
because of the evidence that 2-methyl-1:4-naphthoquinone (menadione) may be
more effective as an electron carrier in tumour tissue than in normal liver (Strength
and Siebert, 1955) it was decided to study the effect of Synkavit on oxidative
phosphorylation processes in the ascites tumour cell. In this connection, it is
interesting that thyroxine (Darcis and Closon, 1959), tri-iodothyronine (Stein and
Grimm, 1959) and dinitrophenol (Mitchell and Simon-Reuss, 1952), all effective
uncouplers of oxidative phosphorylation, can act as radiosensitizers.
MATERIALS AND METHODS
Ascites tumour.-In the first two in vivo experiments, the tumour used was
the Ehrlich ascites tumour which has been carried in our laboratory by routine
transplantation for some years. The in vitro experiments were carried out on a
strain of ascites tumour introduced into this country by Dr. G. DiVita from Italy.
Both tumours were used on the 7th or 8th day after transplantation.
Estimation of ATP.-Cell extracts were assayed enzymatically using the kits
produced by C. F. Boehringer and Soehna-Grub. The oxidation of nicotinamide-EFFECT OF SYNKAVIT ON ATP
adenine dinucleotide (NAD) by ATP and 3-phosphoglyceric acid in the presence
of phosphoglycerate kinase and triose phosphate dehydrogenase was followed by
the decrease ofoptical density at 340 m1a in a Unicam S.P. 500 spectrophotometer.
The assay was carried out as described in the instruction leaflet with the following
modifications to allow for the low concentrations of ATP:
(1) 0-6 ml. cell extract was used instead of the recommended 0-2 ml. of de-
proteinised blood.
(2) 0-02 ml. of reduced NAD was added to the blank in order to reduce
the initial reading.
The assay was calibrated by using known solutions ofATP (Sigma), the change
in optical density being proportional to the amount of ATP up to about 150 y per
cuvette.
In vivo experiments. 0-1 ml. of a solution containing 10 mg. (30 /tM) of
Synkavit was injected intraperitoneally into the experimental animals, the con-
trols receiving 041 ml. of physiological saline. Both sets of animals were killed
by asphyxiation with carbon dioxide 20 or 30 minutes later, the abdomen opened
and the ascitic fluid removed. Any haemorrhagic tumours were rejected. An
aliquot of the combined fluids from the treated and control animals was spun
down in a haematocrit tube to determine the proportion of cells to fluid in each
sample. Equal volumes of the cell suspension from each group were taken, the
cells broken by freezing and thawing, treatment with ultrasonic vibrations for
10 minutes in an ice-bath, and freezing and thawing once more. They were then
extracted 5 times with 2 volumes of ice-cold 5 per cent trichloracetic acid which
was removed byether extraction. Nitrogen was bubbled through to remove ether
and the extracts assayed for ATP.
In vitro experiments.-The ascitic fluid was filtered through muslin to remove
any coagulated material, and equal volumes of the cell suspension pipetted into
Warburg vessels. The vessels were equilibrated for at least 15 minutes, Synkavit
solution was then tipped into the experimental vessels, and an equal volume of
glass distilled water into the control vessels. Readings of oxygen uptake were
then taken every 5 minutes for half an hour. At the end ofthis period the vessels
were chilled by standing in ice-water. The contents of duplicate vessels were
combined in centrifuge tubes, an equal volume of 12 per cent perchloric acid added
and the contents mixed well, keeping the tubes in the ice-bath throughout. The
cell debris was removed by centrifugation in the cold and the extract neutralised
to pH 7 with potassium hydroxide solution. The neutral solutions were left
standing in ice for half an hour, and the precipitate of potassium perchlorate
spun down. The ATP estimations were usually carried out immediately after
the manometric experiments, but estimations after the solutions had been kept
at 4-40 C. overnight showed no significant decrease.
RESULTS AND DISCUSSION
1. In vivo experiments.-The results from the two preliminary in vivo experi-
ments are given in Table I. On a packed cell basis, the treated extract contained
41 per cent of the control ATP in the first experiment and 24-5 per cent of that
in the second.
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TABLE I.-Effect of Intraperitoneal Injection of 30 /UM Synkavit on ATP
Length of % of cells ATP ATP
treatment in y/ml. y/ml.
(minutes) suspension suspension packed cells
30 . Treated . 264 . 18-2 . 69
Control . 32 3 54-6 . 169
20 . Treated . 30 8 . 26 7 . 86-7
Control . 184 . 65 . 354
TABLE II.-Effect of Varying Concentrations ofSynkavit on Concentration of
ATP in Ascites Tumour Cells
Final M Length of
concentration treatment y ATP/ml. % decrease % change in
Experiment Synkavit (minutes) fluid in ATP 02 uptake
1 .. . 30 . 458 .
3 x 10-6 31*7 31 +9
3 x 10-4 30 7 33 +8
2 . .. . 40 . 109 .
3 x 10-2 18-3 83 -29
3 . .. . 30 . 109 79
3 x 1-2 22-8 79 -8
3 x 1-4 63 42 +11
4 . .. . 30 . 28-5 .
3 x 10-6 22-8 20 -2
5 . .. . 30 . 51*8 .
1-5 x 10-3 45 8 19 -17
2. In vitro experiments.-The results of all the in vitro experiments are given
in Table II. The percentage stimulation of oxygen uptake over the same period
is given in the final column. In all the experiments there was a decrease in the
amount of enzymatically estimable ATP in the extracts from cells treated with
Synkavit for half an hour compared with the controls. Except for Experiment 5,
increasing the concentration of Synkavit decreased the amount of ATP present.
The stimulation or inhibition of respiration has no direct relation to this decrease
in ATP.
3. Effects of Synkavit on endogenous respiration ofascites tumour cells. Prelim-
inary experiments had been carried out to test the effect of Synkavit on the
endogenous respiration of these cells, and the results of all experiments on the
oxygen uptake of the tumour after treatment with Synkavit are summarised in
Table III. This shows that we never observed the very great stimulation of
respiration found by Tiedeman et al. (1958). There was a slight stimulation of
respiration in some experiments at very low concentrations. At very high con-
centrations ofthe compound there was a consistent inhibition ofrespiration. These
results show that although part of the observed decrease in ATP in the treated
cells at high Synkavit concentrations may be due to an inhibition of respiration,
at low concentrations where the oxygen uptake is unaffected or slightly stimu-
lated, there is still a considerable decrease in ATP in the cells.
Possible effect of Synkavit on the assay procedure
A standard solution containing 20 jug. ATP in 0-1 ml. was assayed six times.
For the first two assays distilled water was added to bring the volume up toEFFECT OF SYNKAVIT ON ATP 463
TABLE III.-Effects ofSynkavit on Endogenous Respiration of
Ascites Tumour Cells
,ul/hr/ml. ascites fluid % Change
M conc. , A. 5
Experiment Synkavit First 5 mins. Half-hour Initial Half-hour
1 . .. . 204 126
3 x 10-2 168 106 -18 -16
3 x 10-4 240 134 +18 +6
*2 . .. . .. 42-5
3 x 10-2 .. 17-5 .. -59
3 x 10-4 .. 46 .. +8
3 . .. . 216 151 . .. ..
3 x 10-2 174 107 -19 -29
4 . .. . 456 310
3 x 10-4 588 313 +29 +1
5 . .. . 180 447
3 x 10-6 186 429 +3 -4
6 . .. . 222 222
1-5 x 10-a 183 183 -17-5 -17
* Tumour was 14 days old.
0-6 ml. Inthe other assays solutions ofSynkavit were added to bringthe Synkavit
concentration to 1 x 1O-2M and 1 x 10-4M.
The changes in optical density in 5 minutes were as follows:
ATP alone 0-079 ± 6 per cent
ATP + 1 X 10-2 M Synkavit 0-0495 ± 1 per cent
ATP + 1 x 10-4 M Synkavit 0-072 ± 3 per cent
Thus at the highest concentrations of Synkavit added, as much as 36 per cent
of the observed decrease in ATP may be due to an interference with the assay
procedure. This value is probably a maximum however, since the Synkavit has
almost certainly beeen altered chemically at the end of half an hour. Material
fixed to proteins or changed to a quinone is not extracted by the trichloracetic
acid (Chipperfield andMarrian, unpublished) so thatthe concentration ofSynkavit
in the extracts is probably very low. At the lower concentration of Synkavit the
possible error in the assay is not significant.
It has been suggested that quinol phosphates could be involved in phosphoryl-
ation processes accompanying the passage of electrons from substrates to oxygen
inside living cells (Clark, Kirby and Todd, 1958; Harrison 1958). Clark et al.
showed that if Synkavit were oxidised in the presence of inorganic phosphate,
pyrophosphate was formed, and in a later paper (Clark, Hutchinson and Todd,
1960) that ADP could similarly be produced from AMP. More recently, Chmielew-
ska (1960) and Dallam (1961) have suggested mechanisms for oxidative phos-
phorylation in which the presence of an isoprene unit on position 3 ofthe quinone
molecule is necessary for phosphorylation to take place. A quinone which did not
have such a substituent could act as a carrier of electrons, but could not be a
coenzyme for oxidative phosphorylation. Recent support for these theories has
come from the work in bacteria by Russell and Brodie (1961) who showed that
,/-chroman derivatives ofVitamin K1 and analogous compounds could be detected
in bacterial preparations which were capable of oxidative phosphorylation. Only
compounds which were capable of forming this chroman ring were active in464 BARBARA CHIPPERFIELD AND D. H. MARRIAN
restoring phosphorylation to ultra-violet-irradiated bacterial preparations. Fur-
thermore, it has been shown that liver mitochondria from X-irradiated animals
had a reduced capacity for oxidative phosphorylation andthat pre-treatment with
either Vitamin K1 or Vitamin E lessenedthe effect (Nitz-Litzow and Buh.rer, 1960).
If Synkavit is dephosphorylated inside the ascites tumour cell, the menadione
produced could take part in the transfer of electrons from substrates to oxygen,
but not in the accompanying phosphorylation processes. Our results could there-
fore be due to the menadione taking part in the electron transport processes of
the ascites cell in place of Co-enzyme Qlo or some related natural quinone. This
electron transport could not produce ATP, so the net result would be a decrease
in ATP in the treated cells, the cell respiration being essentially unaltered. How-
ever, the observed decrease in ATP in the cell might also be due to a stimulatiod
of the hexose monophosphate pathway of metabolism. Wenner, Hackney and
Moliterno (1958) showed that menadione and other compounds stimulated the
metabolism of glucose along this pathway in ascites tumour cells and it has since
been shown (Hoskin, 1960) that Synkavit as well as menadione has a stimulatory
effect on the hexose monophosphate shunt in brain tissue, whichresembles tumour
tissue in having a low concentration of NAD. This stimulation could be due to
the menadione preferentially oxidising NADPH2, which is produced by the
enzymes oxidising glucose-6-phosphate. This would divert the glucose-6-phosphate
and cause thestriking inhibition of aerobic glycolysis observed byTiedemann et al.
(1958) in ascites tumour cells.
Similar work on other quinones suggests, however, that the decrease in ATP
and the effect on glycolysis may be secondary effects due to an effect on NAD.
Tiedemann and Risse (1960) studying the effects of 9:10-phenanthraquinone and a
water-soluble derivative on ascites tumours showedthatthis quinone alsoinhibited
glycolysis. There was a marked reduction in ATP and a sharp fall in the level of
NAD. In the absence of glucose the only effect observed was a fall in the NAD
content, suggesting that the effect on NAD was the primary one. Since Quaglia-
riello et al. (1959) have claimedthat vitamins K1 and K2, menadione and Synkavit
inhibit the synthesis ofnicotinic acid, a decrease in NAD could be the cause ofthe
decrease in ATP and inhibition ofglycolysis.
SUMMARY
Theradiosensitising agent, Synkavit, reduces the ATP contentofEhrlichmouse
ascites tumour cells in vivo at dose levels of about lu Mole/gram and in vitro at
concentrations between 3 x 10-2 and 3 x 10-6 molar. The higher concentration
of the substance reduced the respiration, while the low concentration caused a
small stimulation in vitro.
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